Procter and Gamble   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cincinnati OH United States (1837)
Status: Acquired by Warner Chilcott (2009) → now AbbVie (2019)

Organization Overview

First Clinical Trial
1988
NCT01582282
First Marketed Drug
1953
nitrofurantoin (furadantin)
First NDA Approval
1953
nitrofurantoin (furadantin)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

P&G | P&G Pharmaceuticals | P&G Pharmaceuticals, Clinical Development Europe | Procter and Gamble | PROCTER AND GAMBLE | Procter & Gamble Beauty | Proctor and Gamble/Aventis